Kirk L. Cumpston

981 total citations
53 papers, 585 citations indexed

About

Kirk L. Cumpston is a scholar working on Emergency Medicine, Pharmacology and Plant Science. According to data from OpenAlex, Kirk L. Cumpston has authored 53 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Emergency Medicine, 9 papers in Pharmacology and 8 papers in Plant Science. Recurrent topics in Kirk L. Cumpston's work include Poisoning and overdose treatments (27 papers), Pesticide Exposure and Toxicity (6 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). Kirk L. Cumpston is often cited by papers focused on Poisoning and overdose treatments (27 papers), Pesticide Exposure and Toxicity (6 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). Kirk L. Cumpston collaborates with scholars based in United States, Czechia and Norway. Kirk L. Cumpston's co-authors include Brandon K. Wills, Taylor A. Ochalek, F. Gerard Moeller, Tamas S. Gal, S. Rutherfoord Rose, Paul E. Stromberg, Jerrold B. Leikin, Sean M. Bryant, Carl E. Wolf and Timothy B. Erickson and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Movement Disorders.

In The Last Decade

Kirk L. Cumpston

49 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kirk L. Cumpston United States 13 168 151 72 69 68 53 585
Brandon K. Wills United States 15 215 1.3× 160 1.1× 76 1.1× 101 1.5× 70 1.0× 72 729
Barbara Insley Crouch United States 14 300 1.8× 90 0.6× 74 1.0× 59 0.9× 27 0.4× 48 675
Stuart E. Heard United States 8 426 2.5× 97 0.6× 102 1.4× 78 1.1× 30 0.4× 11 731
Katarzyna Michaud Switzerland 21 277 1.6× 91 0.6× 43 0.6× 27 0.4× 73 1.1× 73 1.3k
Antoine Villa France 17 92 0.5× 73 0.5× 37 0.5× 68 1.0× 23 0.3× 76 685
Rais Vohra United States 14 152 0.9× 56 0.4× 63 0.9× 39 0.6× 20 0.3× 52 551
Stephen L. Thornton United States 14 126 0.8× 72 0.5× 120 1.7× 35 0.5× 27 0.4× 57 550
Douglas J. Borys United States 15 484 2.9× 95 0.6× 110 1.5× 99 1.4× 39 0.6× 29 1.1k
Frank F S Daly Australia 12 280 1.7× 53 0.4× 55 0.8× 66 1.0× 91 1.3× 21 699
Kaitlyn Brown United States 10 121 0.7× 64 0.4× 30 0.4× 42 0.6× 22 0.3× 22 437

Countries citing papers authored by Kirk L. Cumpston

Since Specialization
Citations

This map shows the geographic impact of Kirk L. Cumpston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk L. Cumpston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk L. Cumpston more than expected).

Fields of papers citing papers by Kirk L. Cumpston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk L. Cumpston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk L. Cumpston. The network helps show where Kirk L. Cumpston may publish in the future.

Co-authorship network of co-authors of Kirk L. Cumpston

This figure shows the co-authorship network connecting the top 25 collaborators of Kirk L. Cumpston. A scholar is included among the top collaborators of Kirk L. Cumpston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk L. Cumpston. Kirk L. Cumpston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wills, Brandon K., et al.. (2024). Peri-mortem rigidity in a fatal case of severe salicylate poisoning. Clinical Toxicology. 62(4). 267–268.
2.
Wilks, Martin F., Christopher Hoyte, Kirk L. Cumpston, et al.. (2024). The Clinical Toxicology Recommendations Collaborative: purpose, organization, and methodology. Clinical Toxicology. 62(2). 76–81. 1 indexed citations
3.
Rose, S. Rutherfoord, et al.. (2024). Outcomes of ingested superabsorbent polymers (“water beads”): A poison center study. The American Journal of Emergency Medicine. 89. 24–26.
4.
Ochalek, Taylor A., Tamas S. Gal, Brandon K. Wills, et al.. (2023). Rapid induction onto extended-release injectable buprenorphine following opioid overdose: A case series. SHILAP Revista de lepidopterología. 7. 100144–100144. 3 indexed citations
5.
Cumpston, Kirk L., et al.. (2022). Systemic toxicity from subcutaneous brimonidine injection successfully treated with naloxone. The American Journal of Emergency Medicine. 59. 218.e5–218.e6. 1 indexed citations
6.
Wills, Brandon K., et al.. (2022). Retained bullets and lead toxicity: a systematic review. Clinical Toxicology. 60(10). 1176–1186. 12 indexed citations
7.
Wills, Brandon K., S. Rutherfoord Rose, Kirk L. Cumpston, et al.. (2019). Prevalence of hematologic toxicity from copperhead envenomation: an observational study. Clinical Toxicology. 58(4). 262–265. 6 indexed citations
8.
Cumpston, Kirk L., et al.. (2018). Update on Current Treatment of Acute Opioid Overdose. Current Treatment Options in Psychiatry. 5(3). 301–312. 2 indexed citations
9.
Cumpston, Kirk L., et al.. (2017). Collaborative Public Health Investigation of Clenbuterol-Adulterated Heroin Outbreak—Richmond, Virginia, March-April 2015. Journal of Public Health Management and Practice. 23(2). e8–e11. 3 indexed citations
10.
Moss, Michael J., et al.. (2016). Dofetilide in Overdose: A Case Series from Poison Center Data. Cardiovascular Toxicology. 17(3). 368–371. 2 indexed citations
11.
Wolf, Carl E., et al.. (2016). A Case Series of Clenbuterol Toxicity Caused by Adulterated Heroin. Journal of Emergency Medicine. 51(3). 259–261. 15 indexed citations
12.
Cumpston, Kirk L., et al.. (2015). Methanol Kinetics in Chronic Kidney Disease After Fomepizole: A Case Report. American Journal of Therapeutics. 23(6). e1949–e1951. 2 indexed citations
13.
Nguyen, Tammy, et al.. (2015). Lack of adverse effects from flumazenil administration: an ED observational study. The American Journal of Emergency Medicine. 33(11). 1677–1679. 8 indexed citations
14.
Wills, Brandon K., et al.. (2014). Clinical Outcomes in Newer Anticonvulsant Overdose: A Poison Center Observational Study. Journal of Medical Toxicology. 10(3). 254–260. 50 indexed citations
15.
Stromberg, Paul E. & Kirk L. Cumpston. (2013). Cases from NACCT acute and intensive care symposium: Altered mental status, seizures, and rash in a fumigation company employee. Clinical Toxicology. 51(3). 182–185. 2 indexed citations
16.
Cumpston, Kirk L.. (2011). Is there a role for fasciotomy in Crotalinae envenomations in North America?. Clinical Toxicology. 49(5). 351–365. 45 indexed citations
17.
Prendergast, Heather M., et al.. (2005). Myocardial infarction and cardiac complications in emergency department patients admitted to the intensive care unit with gastrointestinal hemorrhage. Journal of Emergency Medicine. 28(1). 19–25. 3 indexed citations
18.
Leikin, Jerrold B., et al.. (2004). Characteristics of Patients with No Underlying Toxicologic Syndrome Evaluated in a Toxicology Clinic. Journal of Toxicology Clinical Toxicology. 42(5). 643–648. 5 indexed citations
19.
Bryant, Sean M., et al.. (2004). Metformin-Associated Respiratory Alkalosis. American Journal of Therapeutics. 11(3). 236–237. 3 indexed citations
20.
Bryant, Sean M., et al.. (2003). Facial nerve neuritis secondary to ultraviolet radiation.. PubMed. 45(4). 217–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026